A study to investigate the safety of additional treatment with Vitamin B3 in children with Juvenile Idiopathic Arthritis (JIA)

Registry ID

EUCTR2016-003643-10

Source registry

EUCTR

Phase

PHASE2

Sponsor

UMC Utrecht

Start date

2017-08-31

Last update

2026-08-16

Conditions

• Juvenile idiopathic arthritis (JIA)

Summary

In this phase II trial essential information will be gained on safety, feasibility and tolerability of NAM as an additional treatment in JIA patients.

Locations

• , , Netherlands

View on source registry